Nebraska Cancer Specialists — Omaha, Nebraska

Nebraska Cancer Specialists is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists has participated in 110 clinical trials with 52 currently active.

Therapeutic areas: Pancreatic Ductal Adenocarcinoma, Gastric Cancer, Esophageal Cancer.

Sponsors: Perspective Therapeutics, MacroGenics, Takeda.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists?

Nebraska Cancer Specialists has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists conducted?

Nebraska Cancer Specialists has 110 clinical trials on record, with 52 currently active. Their work covers Pancreatic Ductal Adenocarcinoma, Gastric Cancer, Esophageal Cancer.

Is Nebraska Cancer Specialists accredited by Crixeo Health?

Nebraska Cancer Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.